Published by on Jan 9th, 2007 in Macular Degeneration Vitamins with No Comments
Diplomat Specialty Pharmacy, the nation’s largest independent specialty pharmacy in the nation, announced today it has received limited distribution rights from Regeneron for its new drug EYLEA™ (aflibercept) Injection. On November 18, 2011, EYLEA (aflibercept) Injection was approved by the Food and Drug Administration and is indicated for the treatment of neovascular (wet) age-related macular degeneration (AMD). Macular degeneration is diagnosed as either dry (non-vascular) or wet (vascular) and is a leading cause of blindness in older adults. The wet form usually leads to more serious vision loss.
(PRWeb January 09, 2012)
Read the full story at
Tags:
Published by on Jan 7th, 2007 in Macular Degeneration Vitamins with No Comments
“As we begin 2012, we are making raising awareness about glaucoma a priority’” stated Connecticut Ophthalmologist Leslie Doctor, M.D. of Doctor & Associates with offices located in Westport, Norwalk and Wilton.
(PRWeb January 07, 2012)
Read the full story at
Tags:
Published by on Jan 5th, 2007 in Macular Degeneration Vitamins with No Comments
“At Eyecare Medical Group in Portland, Maine, January represents the time we pay particular attention to getting the word out reminding patients to take advantage of the advances in the diagnosis and treatment of glaucoma as this sight stealing eye disease is a leading cause of preventable blindness,” commented Clement Berry, Chief Executive Officer of Eyecare Medical Group.
(PRWeb January 05, 2012)
Read the full story at
Tags:
Published by on Dec 27th, 2007 in Macular Degeneration Vitamins with No Comments
Residents of Clearwater and Tampa Bay Are Invited to Sign Up for the Eye Shop Grand Opening Event
(PRWeb December 27, 2011)
Read the full story at
Tags:
Published by on Dec 27th, 2007 in Macular Degeneration Vitamins with No Comments
Residents of Clearwater and Tampa Bay Are Invited to Sign Up for the Eye Shop Grand Opening Event
(PRWeb December 27, 2011)
Read the full story at
Tags: